PMC:7200337 / 72655-72744
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T433","span":{"begin":71,"end":79},"obj":"Disease"}],"attributes":[{"id":"A433","pred":"mondo_id","subj":"T433","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Multiple studies also aimed to repurpose protease inhibitors to reduce SARS-CoV-2 titers."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T23982","span":{"begin":41,"end":60},"obj":"Chemical"},{"id":"T79279","span":{"begin":50,"end":60},"obj":"Chemical"}],"attributes":[{"id":"A9528","pred":"chebi_id","subj":"T23982","obj":"http://purl.obolibrary.org/obo/CHEBI_37670"},{"id":"A58721","pred":"chebi_id","subj":"T23982","obj":"http://purl.obolibrary.org/obo/CHEBI_60258"},{"id":"A50749","pred":"chebi_id","subj":"T79279","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"Multiple studies also aimed to repurpose protease inhibitors to reduce SARS-CoV-2 titers."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"2315","span":{"begin":61,"end":63},"obj":"Gene"},{"id":"2316","span":{"begin":28,"end":30},"obj":"Gene"},{"id":"2322","span":{"begin":71,"end":81},"obj":"Species"}],"attributes":[{"id":"A2315","pred":"tao:has_database_id","subj":"2315","obj":"Gene:6999"},{"id":"A2316","pred":"tao:has_database_id","subj":"2316","obj":"Gene:6999"},{"id":"A2322","pred":"tao:has_database_id","subj":"2322","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Multiple studies also aimed to repurpose protease inhibitors to reduce SARS-CoV-2 titers."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T407","span":{"begin":0,"end":89},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Multiple studies also aimed to repurpose protease inhibitors to reduce SARS-CoV-2 titers."}